Another research implies that regulation of GPX4 by SRSF9 is a critical mechanism driving CRC tumorigenesis as well as resistance to Erastin-induced ferroptosis, which may provide a new idea to enhance the sensitivity to Erastin in CRC cells [72]. This evidence concerns the gene GPX4 and colorectal carcinoma.